Constitution: The Kokate Committee was constituted by Ministry Of Health And Family Welfare, Government of India, under the chairmanship of Prok. C.K. Kokate, VC, KLE University, Belgaum, Karnataka.(1) The need to constitute the Kokate Committee: Drug Controller General India (DCGI) had issued a letter dated 15.01.2013 to all the State […]
In order to strengthen the scientific review and approval of new drugs/devices, the ministry has appointed 12 New Drug Advisory Committee’s (NDAC), Subject Expert Committees (SEC) and 7 Medical Device Advisory Committee’s (MDAC) to advise the CDSCO in making their decisions on approval of new drugs and global clinical trials.
Read MoreDefinitions of New Drug, FDC, SND and associated form
Read MoreDrug product registration and licensing in Europe, Africa, Asia, the Middle East and South America
Read More
National e-Governance plan (NeGP), launched in 2006 as initiative that Government of India has implemented to make all government services accessible online.
Read MoreGlobal Licensing and Registration, Product Registration Process – a strategy that ensures optimum results, Dossier Preparation for Export and Registration, Writing & Review of- Summaries and Drug Master File
Read MoreThe Indian government has brought about some major changes with regards to the rules and regulations governing the manufacturing to enhance the quality of products used in the healthcare industry. As India being a major market for the healthcare-related products and its services, these modifications to the existing regulations are […]
Indian Government has chosen to join the foray and ride the digital wave through SUGAM, launched on 14 November, 2015
The Central Drugs Standard Control Organization (CDSCO) plays an important role in safeguarding and enhancing public health by ensuring the quality, safety, and efficacy of drugs, cosmetics, and medical devices. It is the Central Drug Authority for fulfilling functions allocated to the Central Government under the Drugs and Cosmetics Act. […]
